top of page

Prostate Cancer

US Patent Application 20130059018 A1, Mar 7, 2013 - Phytocannabinoids in the treatment of cancer

Towards the use of non-psychoactive cannabinoids for prostate cancer

Pacher, Pal, et al.

British Journal of Pharmacology. 2013, 168: 76-78 (Full).

Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells

Nithipatikom, Kasem, et al.

Endocrinology. 2012 Jan, 153(1): 29-41 (Full).

The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications

Ramos, Juan A, et al.

Indian Journal of Urology. 2012 Mar, 28(1): 9-14 (Full).

Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent

Sreevalasan, Sandeep, et al.

Anticancer Research: International Journal of Cancer Research and Treatment. 2011, 31: 3799-3808 (Full).

The endocannabinoid system in prostate cancer

Diaz-Laviada, Ines, et al.

Nature Reviews Urology. 2011 Oct, 8: 553-561 (abstract).

Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines

Browin, Iain, et al.

Carcinogenesis. 2010, 31(9): 1584-1591 (Full).

Tumour Cannabinoid CB1 Receptor and Phosphorylated Epidermal Factor Receptor Expression Are Additive Prognostic Markers for Prostate Cancer

Fowler, Christopher, et al.

PLOS One. 2010 Dec, 5(12) (Full online article).

The cannabinoid R(+)methanandamide induces IL-6 secretion by prostate cancer PC3 cells

Olea-Herrero, Nuria, et al.

Journal of Immunotoxicology. 2009 Dec, 6(4): 249-256 (abstract).

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2

Olea-Herrero, N, et al.

British Journal of Cancer. 2009, 101: 940-950 (Full).

Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma

Czifra, Gabriella, et al.

Journal of Cancer Research and Clinical Oncology. 2009 Apr, 135(4): 507-514 (abstract).

Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8

De Petrocellis, Luciano, et al.

The Journal of Pharmacology and Experimental Therapeutics. 2008, 325(3): 1007-1015 (Full).

Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism

Endsley, Michael P, et al.

International Journal of Cancer. 2007 Apr 18, 121(5): 984-991 (Full).

Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle Arrest

Sarfaraz, Sami, et al.

The Journal of Biological Chemistry. 2006, 281: 39480-39491 (Full).

A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells

Kogan, Natalya, et al.

Molecular Pharmacology. 2006, 70: 51-59 (Full).

Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer

Sarfaraz, Sami, et al.

Cancer Research. 2005, 65: 1635-1641 (Full).

A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells

Nithipatikom, Kasem, et al.

Biochemical and Biophysical Research Communications. 2005 Jul 15, 332(4): 1028-1033 (abstract).

2-Arachidonoylglycerol: A Novel Inhibitor of Androgen Independent Prostate Cancer Cell Invasion

Nithipatikom, Kasem, et al.

Cancer Research. 2004, 64: 8826-8830 (Full).

Pharmacokinetics and Pharmacodynamics of Cannabinoids

Grotenhermen, Franjo, et al.

Clinical Pharmacokinetics. 2003 Apr, 42(4): 327-360 (abstract).

Δ9-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells

Velasco, Lara, et al.

European Journal of Biochemistry. 2001 Feb, 268(3): 531-535 (Full).

Δ9-Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism

Ruiz, Lidia, et al.

FEBS Letters. 1999 Sep 24, 458(3): 400-404 (Full).

Prostate Cancer: About Us
bottom of page